Human Health Holdings Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Poon Chun Pong, was filed 28 Jan 2019.
Human Health Holdings Ltd.: what insiders have been doing
Human Health Holdings Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. The past year has been quiet: not a single insider filing for Human Health Holdings Ltd. The previous disclosure was published on 6 October 2022.
Our records for Human Health Holdings Ltd. go back to 2017, with 24 purchases and 2 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Since the insiders bought
- -10.9%Entry HK$1.47 · Close at T+365 HK$1.31
- -19.2%Entry HK$1.98 · Close at T+365 HK$1.60
- -11.1%Entry HK$1.62 · Close at T+365 HK$1.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
- 600,000 sharesShareXHKGHKEX:DA20221006E00049
- 960,000 sharesShareXHKGHKEX:DA20221006E00048
- 74,000 shares@ HK$1.496842.7% of flowShareXHKGHKEX:DA20190128E00288Canonical exit: 24 Apr 2019 (T+90)
- 30,000 shares@ HK$1.4216.5% of flowShareXHKGHKEX:DA20190128E00289Canonical exit: 25 Apr 2019 (T+90)
- 40,000 shares@ HK$1.4121.8% of flowShareXHKGHKEX:DA20190123E00240Canonical exit: 21 Apr 2019 (T+90)
- 34,000 shares@ HK$1.438218.9% of flowShareXHKGHKEX:DA20190123E00241Canonical exit: 22 Apr 2019 (T+90)
- 36,000 shares@ HK$1.96781.0% of flowShareXHKGHKEX:DA20180517E00227Canonical exit: 14 Aug 2018 (T+90)
- 36,000 shares@ HK$1.96781.0% of flowShareXHKGHKEX:DA20180517E00231Canonical exit: 14 Aug 2018 (T+90)
- 234,000 shares@ HK$1.99546.3% of flowShareXHKGHKEX:DA20180511E00347Canonical exit: 8 Aug 2018 (T+90)
- 308,000 shares@ HK$1.99668.3% of flowShareXHKGHKEX:DA20180511E00348Canonical exit: 9 Aug 2018 (T+90)
- 308,000 shares@ HK$1.99668.3% of flowShareXHKGHKEX:DA20180511E00350Canonical exit: 9 Aug 2018 (T+90)
- 234,000 shares@ HK$1.99546.3% of flowShareXHKGHKEX:DA20180511E00349Canonical exit: 8 Aug 2018 (T+90)
- 220,000 shares@ HK$1.99355.9% of flowShareXHKGHKEX:DA20180509E00324Canonical exit: 7 Aug 2018 (T+90)
- 672,000 shares@ HK$1.928417.4% of flowShareXHKGHKEX:DA20180509E00323Canonical exit: 5 Aug 2018 (T+90)
- 672,000 shares@ HK$1.928417.4% of flowShareXHKGHKEX:DA20180509E00326Canonical exit: 5 Aug 2018 (T+90)
- 220,000 shares@ HK$1.99355.9% of flowShareXHKGHKEX:DA20180509E00327Canonical exit: 7 Aug 2018 (T+90)
- 170,000 shares@ HK$1.91054.3% of flowShareXHKGHKEX:DA20180507E00016Canonical exit: 2 Aug 2018 (T+90)
- 184,000 shares@ HK$1.91014.7% of flowShareXHKGHKEX:DA20180507E00015Canonical exit: 1 Aug 2018 (T+90)
- 184,000 shares@ HK$1.91014.7% of flowShareXHKGHKEX:DA20180507E00017Canonical exit: 1 Aug 2018 (T+90)
- 170,000 shares@ HK$1.91054.3% of flowShareXHKGHKEX:DA20180507E00018Canonical exit: 2 Aug 2018 (T+90)
- 90,000 shares@ HK$1.91422.3% of flowShareXHKGHKEX:DA20180503E00022Canonical exit: 31 Jul 2018 (T+90)
- 90,000 shares@ HK$1.91422.3% of flowShareXHKGHKEX:DA20180503E00023Canonical exit: 31 Jul 2018 (T+90)
- 100,000 shares@ HK$1.882.5% of flowShareXHKGHKEX:DA20180427E00249Canonical exit: 25 Jul 2018 (T+90)
- 100,000 shares@ HK$1.882.5% of flowShareXHKGHKEX:DA20180427E00250Canonical exit: 25 Jul 2018 (T+90)
- 18,000 shares@ HK$1.880.4% of flowShareXHKGHKEX:DA20180426E00402Canonical exit: 24 Jul 2018 (T+90)
25 of 46 declarations
About Human Health Holdings Ltd.
Human Health Holdings Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare sector. It focuses on the development and commercialization of innovative solutions to enhance human health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
